A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001
We describes a case of a critically ill patient with myocarditis and severe acute respiratory distress syndrome related to coronavirus disease-2019. This case highlights management strategies, including the use of corticosteroids, an interleukin-6 inhibitor, and an aldose reductase inhibitor, resulting in complete clinical recovery. (Level of Difficulty: Intermediate.).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
JACC. Case reports - 2(2020), 9 vom: 15. Juli, Seite 1331-1336 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Coyle, Justin [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 28.07.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.jaccas.2020.04.025 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309522943 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309522943 | ||
| 003 | DE-627 | ||
| 005 | 20231225134111.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaccas.2020.04.025 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1031.xml |
| 035 | |a (DE-627)NLM309522943 | ||
| 035 | |a (NLM)32368755 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Coyle, Justin |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a We describes a case of a critically ill patient with myocarditis and severe acute respiratory distress syndrome related to coronavirus disease-2019. This case highlights management strategies, including the use of corticosteroids, an interleukin-6 inhibitor, and an aldose reductase inhibitor, resulting in complete clinical recovery. (Level of Difficulty: Intermediate.) | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a 2019-nCoV | |
| 650 | 4 | |a ACS, acute coronary syndrome | |
| 650 | 4 | |a ARDS | |
| 650 | 4 | |a ARDS, acute respiratory distress syndrome | |
| 650 | 4 | |a ARI, aldose reductase inhibitor | |
| 650 | 4 | |a CMR, cardiac magnetic resonance | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a COVID-19, coronavirus disease-2019 | |
| 650 | 4 | |a CT, computed tomography | |
| 650 | 4 | |a ECG, electrocardiogram | |
| 650 | 4 | |a Fio2, fraction of inspired oxygen | |
| 650 | 4 | |a LGE, late gadolinium enhancement | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2 | |
| 650 | 4 | |a aldose reductase inhibitor | |
| 650 | 4 | |a cardiac magnetic resonance | |
| 650 | 4 | |a cardiogenic shock | |
| 650 | 4 | |a corticosteroids | |
| 650 | 4 | |a myocarditis | |
| 650 | 4 | |a tocilizumab | |
| 700 | 1 | |a Igbinomwanhia, Efehi |e verfasserin |4 aut | |
| 700 | 1 | |a Sanchez-Nadales, Alejandro |e verfasserin |4 aut | |
| 700 | 1 | |a Danciu, Sorin |e verfasserin |4 aut | |
| 700 | 1 | |a Chu, Chae |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Nishit |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JACC. Case reports |d 2019 |g 2(2020), 9 vom: 15. Juli, Seite 1331-1336 |w (DE-627)NLM304093653 |x 2666-0849 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2020 |g number:9 |g day:15 |g month:07 |g pages:1331-1336 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaccas.2020.04.025 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2020 |e 9 |b 15 |c 07 |h 1331-1336 | ||